Letter

Some patients stop treatment when variables improve

BMJ 2005; 330 doi: 10.1136/bmj.330.7505.1449-c (Published 16 June 2005)
Cite this as: BMJ 2005;330:1449.4

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. K Kain, senior lecturer in community diabetes (k.kain@leeds.ac.uk),
  2. A J Catto, senior lecturer
  1. Academic Unit of Molecular Vascular Medicine Level 7, The LIGHT Laboratories, Clarendon Way, University of Leeds, Leeds LS2 9JT
  2. Academic Unit of Molecular Vascular Medicine Level 7, The LIGHT Laboratories, Clarendon Way, University of Leeds, Leeds LS2 9JT

    EDITOR—Lawton et al describe perceptions of oral hypoglycaemic agents among people of Pakistani and Indian origin.1 We have observed another phenomenon quite often among patients. When treatment is started in asymptomatic patients with high blood pressure or high plasma glucose picked up on screening the general population, …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular